Assyro AI

FDA Orange Book · active-ingredient family

Propafenone hydrochloride

Propafenone hydrochloride is approved as 2 brand and 16 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:RYTHMOL SR · NDA 021416

2

Brand (NDA)

16

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule, extended release, tablet

ProductApplicantApplicationTEApproved
RYTHMOL SRRLD×3GLAXOSMITHKLINE LLCNDA 021416Sep 04, 2003
RYTHMOLRLD×3GLAXOSMITHKLINE LLCNDA 019151Nov 27, 1989

Generic (ANDA) products (16)

ProductApplicantApplicationTEApproved
PROPAFENONE HYDROCHLORIDE×3AUROBINDO PHARMA LTDANDA 213096ABFeb 21, 2023
PROPAFENONE HYDROCHLORIDE×3ZYDUS LIFESCIENCESANDA 214184ABApr 21, 2021
PROPAFENONE HYDROCHLORIDE×3UPSHER SMITH LABSANDA 212744ABJun 25, 2020
PROPAFENONE HYDROCHLORIDE×3TWI PHARMSANDA 212928Jun 18, 2020
PROPAFENONE HYDROCHLORIDE×3SINOTHERAPEUTICS INCANDA 210339ABJan 04, 2019
PROPAFENONE HYDROCHLORIDE×3RISINGANDA 205956ABJul 02, 2018
PROPAFENONE HYDROCHLORIDE×3GLENMARK PHARMS LTDANDA 205268ABSep 08, 2017
PROPAFENONE HYDROCHLORIDE×3AUROBINDO PHARMAANDA 202445ABMay 11, 2016
PROPAFENONE HYDROCHLORIDE×3MYLANANDA 203803Apr 29, 2016
PROPAFENONE HYDROCHLORIDE×3WATSON LABS INCANDA 202688ABAug 24, 2015
PROPAFENONE HYDROCHLORIDE×3STRIDES PHARMA INTLANDA 078540ABOct 18, 2010
PROPAFENONE HYDROCHLORIDE×3ANI PHARMSANDA 076550ABApr 23, 2004
PROPAFENONE HYDROCHLORIDE×3STRIDES PHARMA INTLANDA 075938ABOct 17, 2002
PROPAFENONE HYDROCHLORIDE×3NESHER PHARMSANDA 076193Feb 07, 2002
PROPAFENONE HYDROCHLORIDE×3SUN PHARM INDUSTRIESANDA 075998Nov 29, 2001
PROPAFENONE HYDROCHLORIDE×2WATSON LABSANDA 075203ABOct 24, 2000

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Propafenone hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.